Biomedical Textiles Market Size, Share, Growth, Trends, and Global Industry Analysis: By Fabric Type (Woven, Non-Woven, and Others), By Fiber Type (Non-biodegradable Fiber, Biodegradable Fiber, and Others), By Application (Implantable, Non-implantable, and Others) and Region Forecast 2024-2030

The biomedical textiles market size was valued at US$ 12,635.7 million in 2023 and is projected to reach US$ 18,749.9 million by 2030, growing at a CAGR of 5.8% from 2024-2030. The drivers are increasing demand for implantable devices, growing chronic diseases, technology advancements, and an aging population. With growth in healthcare spending and better infrastructure, more demand is seen for these advanced medical textiles.

The key barriers to expanding in such markets, mainly in less developed healthcare systems, are high production costs, stringent regulatory approvals, limited awareness among people in emerging markets, and concerns about biocompatibility and biodegradability. New growth areas include emerging markets, eco-friendly textiles, and innovative applications in drug delivery and tissue engineering. R&D investments in smart textiles will open new markets for growth. The key trends are comprised of non-woven materials, biodegradable fibers, antimicrobial textiles, personalized products, and 3D printing for precision medical textile production.

Key Players

The biomedical textiles market share includes several companies such as Elkem ASA, Medline Industries Inc., Poly-Med Incorporated, Cortland Biomedical, Bally Ribbon Mills, Inc., Confluent Medical, Atex Technologies Inc., B. Braun Melsungen AG, DSM, Swicofil AG and others.

Key Takeaways

• Biodegradable fibers are small, but their biodegradability has seen them become increasingly applied in wound healing and drug delivery applications.
• The majority of biomedical textiles used fall in the implantable product category including vascular grafts, sutures, and meshes.
• The North American market region has the highest adoption rate for biomedical textiles, particularly in the United States.

Facts & Figures

• In the United States, 17% or 56 million of the population will be 65 or older in 2024 and are expected to increase their share to 22% by 2050.
• According to the United Nations Department of Economic and Social Affairs, approximately 771 million people had attained the age of 65 or above in 2022, which forms almost 10% of the world's population. This area is likely to reach 16% in the year 2050, and then finally 24% by the year 2100.
• Globally, it is estimated that approximately 313 million surgical procedures are undertaken each year. However, only about 6% of these procedures are performed in low-income countries (LICs), which are home to over one-third of the world's population.
• Health expenditure in the United States has been rising very fast, reaching an estimated $4.5 trillion in 2022, which is $13,493 per person.
• The Lancet Commission on Global Surgery proposed that by 2030, countries should achieve a minimum annual surgical volume of 5,000 procedures per 100,000 population.

Key Developments

• In April 2024: Medline announced that it has signed a definitive agreement to acquire Ecolab, Inc.'s global surgical solutions business, which includes the industry-leading Microtek product lines. Once closed, the acquisition will give Medline innovative sterile drape solutions for surgeons, patients, and equipment within the operating room, as well as Ecolab's fluid temperature management system.
• In January 2022: Confluent Medical announced that TPG Capital agreed to buy a majority stake in the company under a definitive agreement. Existing investor Ampersand Capital Partners will also join as TPG Capital will join an existing investor Ampersand Capital Partner, who maintained a significant minority interest in Confluent.

Biomedical Textiles Market Segmentation

By Fabric Type: Nonwoven fabrics are increasing in demand due to their extensive advantages over woven fabric in that they may comprise finer individual fibers which provide better insulation, filtration, and barrier properties

By Fiber Type: Biodegradable fibers are small but their biodegradability has seen them become increasingly applied in wound healing and drug delivery applications. Non-biodegradable fibers include polyester, and polypropylene among others, and this represents the greater percentage of implantable devices.

By Application: The majority of biomedical textiles used fall in the implantable product category including vascular grafts, sutures, and meshes, while the rest are non-implantable such as wound dressings, and bandages.